Gevo Inc. (GEVO), an energy company specializing in renewable chemicals and advanced biofuels, is projected to achieve earnings of $0.73 per share for the fiscal year 2025, according to a recent research report by HC Wainwright. This estimate represents a downward revision from their previous forecast of $0.88 per share. The consensus estimate for GEVO earnings in the current fiscal year is ($0.29) per share.
The company’s latest earnings announcement was made on Thursday, March 9th, revealing an EPS (earnings per share) of ($0.11) for the quarter. This fell short of analysts’ consensus estimates of ($0.06) by ($0.05). Gevo reported revenue of $0.55 million for the quarter, lower than the projected $0.74 million. Furthermore, Gevo experienced a negative return on equity of 16.14% and a negative net margin of 8,341.02%.
Following these developments, investment firm Stifel Nicolaus lowered GEVO target price from $5.00 to $4.30 and maintained a “Strong buy” rating on the stock, as stated in a research note on Friday, April 14th.
In recent trading, GEVO stock price increased by 1.3% to reach $1.15 per share. The company’s market capitalization stands at $271.56 million, with a price-to-earnings ratio of -2.57 and a beta of 3.04. GEVO stock has ranged from a 52-week low of $1.01 to a high of $4.81, while its fifty-day moving average price is $1.40 and its two-hundred-day moving average price is $1.81.
In terms of investor activity, several major players have made adjustments to their positions in Gevo. Atom Investors LP acquired a new position in the company during the third quarter, valued at approximately $27,000. Tower Research Capital LLC TRC increased its holdings by 726.2% during the first quarter, owning 18,607 shares worth $29,000 after purchasing an additional 16,355 shares. Zacks Investment Management also acquired a new position in Gevo during the third quarter, with an approximate value of $30,000. Similarly, Mosaic Family Wealth Partners LLC and Mariner LLC both obtained new positions in the fourth quarter, valued at approximately $32,000 and $33,000, respectively. Institutional investors and hedge funds currently own 45.83% of GEVO stock.
As investors assess GEVO financial performance and prospects, there is considerable interest in the company’s stock, leading to discussions and debates regarding whether to buy or sell. Additionally, investors are closely monitoring GEVO stock price and seeking forecasts for its future trajectory, particularly in relation to 2023 and 2025. The recent revision of earnings estimates has prompted some analysts to ponder the reasons behind the stock’s decline and evaluate whether it presents a buying opportunity.
Overall, Gevo, Inc. is expected to face challenges in achieving its anticipated earnings for FY2025, leading to revisions in analyst estimates. The GEVO stock performance, influenced by factors such as financial results, market conditions, and investor sentiment, remains a subject of debate and speculation within the investment community.
GEVO Stock Analysis & Forecast
According to three analysts of STA Research, Gevo Inc is expected to reach an average target price of USD 8.18 within the next 12 months, indicating a Strong Buy rating. However, Stock Target Advisor’s analysis of Gevo Inc suggests a slightly bearish outlook, considering three positive signals and five negative signals. Gevo Inc’s stock closed at USD 1.15 in the previous session. Over the past week, the stock price has experienced a decrease of -4.96%, a decrease of -7.26% over the past month, and a significant decrease of -68.06% over the last year.
